, stands as a testament to why she remains a top-tier performer in the industry. The Performer: Nanami Misaki
MEYD‑773 is a highly selective, orally bioavailable PI3K inhibitor with robust preclinical activity against TNBC, including chemoresistant subtypes. These data support advancement of MEYD‑773 into IND‑enabling studies and a first‑in‑human phase I trial in patients with advanced PI3K‑driven TNBC. MEYD-773
Tsukasa Aoi is a well-known figure in the Japanese entertainment industry, having debuted in the late 2000s. Over her career, she has appeared in numerous productions, variety shows, and films, becoming one of the more recognized names associated with the Meidi label during this period. , stands as a testament to why she